Plavix (clopidogrel) to prevent recurrent heart attacks or ischemic strokes

    Sanofi and Bristol-Myers Squibb are promoting Plavix (clopidogrel) to prevent recurrent heart attacks or ischemic strokes.

    Plavix is a new platelet inhibitor. It's similar to Ticlid (ticlopidine)...but without the risk of neutropenia.

    Plavix is slightly more effective than aspirin...and causes slightly less GI bleeding.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote